EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bacillus subtilis natto NTU-18 attenuates atherosclerosis progression by modulating peripheral immune cell alterations

Jian-Da Lin, Yu-Zhen Ye, Sin-Ren Wang, Wen-Yi Kao, Kung-Ta Lee

Applied Microbiology and Biotechnology · 17.10.2025 · 109 (1)

DOI: 10.1007/s00253-025-13604-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied Microbiology and Biotechnology, online erschienen am 17.10.2025. Verfasst von Jian-Da Lin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemical Science and Technology, National Taiwan University, Taipei, 10617, Taiwan. jdlin@ntu.edu.tw. Hauptthemen laut MEDLINE: Atherosclerosis, Bacillus subtilis, Probiotics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, National Taiwan University, Ministry of Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerosis is a chronic inflammatory disease characterized by lipid accumulation and immune dysregulation, including expansion of pro-inflammatory monocytes and effector T cells, alongside reduced regulatory T cells (Tregs). Bacillus subtilis natto, a spore-forming probiotic, has shown anti-atherosclerotic effects, though its systemic immunomodulatory mechanisms remain unclear. In this study, we employed an AAV-mPCSK9-induced murine atherosclerotic model to investigate the effects of daily B. subtilis natto NTU-18 administration over 16 weeks. High-dimensional flow cytometry using two 13-marker panels enabled longitudinal profiling of 18 peripheral immune cell subsets across lymphoid and myeloid compartments. While no significant changes in serum cholesterol and mild decrease of body weight were observed, B. subtilis natto NTU-18-treated mice presented a significant reduction in aortic lesion area compared to PBS-treated controls. Immune profiling revealed a transient expansion of peripheral myeloid cells and CD44⁺ trained CD8⁺ T cells, followed by increased frequencies of naïve CD8⁺ T cells and reduced central/effector memory subsets at longer time point treatment. In the CD4⁺ T cell compartment, a transient increase in trained cells was accompanied by a sustained enrichment of CD25⁺CD4⁺ Tregs throughout the daily B. subtilis natto NTU-18 treatment. In contrast, no significant differences were observed in Ly6C⁻ or Ly6C⁺ monocytes, neutrophils, or eosinophils. These findings suggest that B. subtilis natto NTU-18 attenuates atherosclerosis progression not through lipid lowering or broad myeloid modulation, but via targeted reprogramming of peripheral T cell responses. This work provides mechanistic insight into the immunotherapeutic potential of B. subtilis natto NTU-18 in atherosclerosis prevention and treatment. Key points • B. subtilis natto NTU-18 significantly reduces aortic plaque burden in atherosclerotic mice without affecting serum cholesterol levels . • B. subtilis natto NTU-18 induces transient immune remodeling, marked by early expansion of trained CD8⁺ and CD4⁺ T cells, followed by increased naïve and regulatory T cells . • The atheroprotective effect is primarily mediated through adaptive immunity as myeloid subsets remain unchanged throughout B. subtilis natto NTU-18 treatment .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtherosclerosisBacillus subtilisProbioticsAnimalsMiceDisease Models, AnimalMice, Inbred C57BLT-Lymphocytes, RegulatoryMaleDisease Progression

Stichwörter der Autor:innen

B. subtilis natto NTU-18AtherosclerosisEffector memory T cellsHigh-dimensional flow cytometryProbioticsRegulatory T cells (Tregs)

Autor:innen und Institutionen

  • Department of Biochemical Science and Technology, National Taiwan University, Taipei, 10617, Taiwan. jdlin@ntu.edu.tw.
  • Center for Computational and Systems Biology, National Taiwan University, Taipei, 10617, Taiwan. jdlin@ntu.edu.tw.
  • Center for Advanced Computing and Imaging in Biomedicine, National Taiwan University, Taipei, 10617, Taiwan. jdlin@ntu.edu.tw.
  • Department of Biochemical Science and Technology, National Taiwan University, Taipei, 10617, Taiwan.

Förderung

  • National Science and Technology Council
  • National Taiwan University
  • Ministry of Education

Zitieren

APA

Lin, J. D., Ye, Y. Z., Wang, S. R., Kao, W. Y., & Lee, K. T. (2025). Bacillus subtilis natto NTU-18 attenuates atherosclerosis progression by modulating peripheral immune cell alterations. Applied Microbiology and Biotechnology, 109(1). https://doi.org/10.1007/s00253-025-13604-0

Vancouver

Lin JD, Ye YZ, Wang SR, Kao WY, Lee KT. Bacillus subtilis natto NTU-18 attenuates atherosclerosis progression by modulating peripheral immune cell alterations. Applied Microbiology and Biotechnology. 2025;109(1). doi:10.1007/s00253-025-13604-0

BibTeX
@article{Lin2025,
  author = {Lin, Jian-Da and Ye, Yu-Zhen and Wang, Sin-Ren and Kao, Wen-Yi and Lee, Kung-Ta},
  title = {Bacillus subtilis natto NTU-18 attenuates atherosclerosis progression by modulating peripheral immune cell alterations},
  journal = {Applied Microbiology and Biotechnology},
  year = {2025},
  volume = {109},
  number = {1},
  doi = {10.1007/s00253-025-13604-0}
}
Kostenlos starten →